← FDA DRUG APPROVALS

FDA ANDA · ANDA072326

FENOPROFEN CALCIUM

Sponsor: DAVA PHARMS INC

APPLICATION
ANDA072326
TYPE
ANDA
ORIGINAL APPROVAL
1988-04-20
LATEST ACTION
1999-11-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FENOPROFEN CALCIUMDiscontinued
FENOPROFEN CALCIUM EQ 600MG BASE · TABLET · ORAL

Approval history

1999-11-04Manufacturing (CMC) · Supplement 9AP
1999-11-04Manufacturing (CMC) · Supplement 10AP
1998-12-01Manufacturing (CMC) · Supplement 8AP
1995-10-06Manufacturing (CMC) · Supplement 7AP
1991-04-15Manufacturing (CMC) · Supplement 6AP
1989-03-31Labeling · Supplement 5AP
1988-12-15Manufacturing (CMC) · Supplement 2AP
1988-12-15Manufacturing (CMC) · Supplement 3AP
1988-07-20Manufacturing (CMC) · Supplement 1AP
1988-04-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →